Literature DB >> 427031

The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermedia.

E Gallo, P Massaro, R Miniero, D David, C Tarella.   

Abstract

Twelve carriers of thalassaemia intermedia were studied. Their clinical and haematological picture was distinctly different from that in both heterozygotes and homozygotes for beta thalassaemia. Several genetic patterns were found responsible for thalassaemia intermedia: beta/delta beta thalassaemia, alpha 2 beta/beta thalassaemia-heterocellular HPFH. In a few subjects the genetic picture indicated that the patients were homozygous for beta thalassaemia, in spite of the mildness of the clinical situation. The lack of genetic uniformity was refelcted in very wide Hb A2 (2.5--8.7%) and Hb F (7.5--96.9%) ranges, as opposed to the noticeable degree of biochemical uniformity indicated by the very similar imbalance of globin chain synthesis: 0.33-0.54 for the non-alpha/alpha chain ratio in the peripheral blood. The mean for this parameter (0.43 +/- 0.05) was significantly different (P less than 0.001) from that observed in heterozygous carriers (0.60 +/- 0.10) and homozygous carriers (0.11 +/- 0.05) for beta thalassaemia. The marrow blood displayed a comparable pattern. It is therefore suggested that the severity of thalassaemia is attributable to the degree of chain synthesis imbalance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427031     DOI: 10.1111/j.1365-2141.1979.tb05850.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  Fetal globin induction--can it cure beta thalassemia?

Authors:  Susan P Perrine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

2.  Hematological responses to hydroxyurea therapy in multitransfused thalassemic children.

Authors:  V P Choudhry; A Lal; H P Pati; L S Arya
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

3.  beta+-Thalassemia intermedia with low HbF.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  Klin Wochenschr       Date:  1983-01-17

4.  Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.

Authors:  Susan P Perrine; Serguei A Castaneda; Michael S Boosalis; Gary L White; Brandon M Jones; Regine Bohacek
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

5.  Fetal globin gene inducers: novel agents and new potential.

Authors:  Susan P Perrine; Serguei A Castaneda; David H K Chui; Douglas V Faller; Ronald J Berenson; Noppadol Siritanaratku; Suthat Fucharoen
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

6.  Beta-Thalassaemia types in southern Sardinia.

Authors:  A Cao; M Furbetta; A Ximenes; A Angius; C Rosatelli; T Tuveri; M T Scalas; A M Falchi; L Maccioni; M A Melis; R Galanello
Journal:  J Med Genet       Date:  1981-06       Impact factor: 6.318

7.  A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.

Authors:  Suthat Fucharoen; Adlette Inati; Noppadol Siritanaratku; Swee L Thein; William C Wargin; Suzanne Koussa; Ali Taher; Nattawara Chaneim; Michael Boosalis; Ronald Berenson; Susan P Perrine
Journal:  Br J Haematol       Date:  2013-03-27       Impact factor: 6.998

8.  Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.

Authors:  Robert A Parise; Jan H Beumer; Cyrous O Kangani; Julianne L Holleran; Julie L Eiseman; Nicola F Smith; Joseph M Covey; Susan P Perrine; Merrill J Egorin
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-08       Impact factor: 3.205

9.  Thalassaemia intermedia in a family with beta 0-thalassaemia and Hb Hasharon.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

10.  Can homeopathy bring additional benefits to thalassemic patients on hydroxyurea therapy? Encouraging results of a preliminary study.

Authors:  Antara Banerjee; Sudipa Basu Chakrabarty; Susanta Roy Karmakar; Amit Chakrabarty; Surjyo Jyoti Biswas; Saiful Haque; Debarsi Das; Saili Paul; Biswapati Mandal; Boujedaini Naoual; Philippe Belon; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.